Phase 1b/2 Study of Autologous CD30.CAR-T Cells in Combination with Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma after Failure of Frontline Therapy (ACTION)

Authors :: Matthew Mei
Sairah Ahmed
Amer Beitinjaneh
Natalie S. Grover
Carlos A. Ramos
Khong Bee Kang
Paul I. Nadler
Aung Myo
Ivan D. Horak
Helen E. Heslop
Source :: Blood. 140:12728-12730
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools